GoodRx (GDRX) Competitors $5.05 +0.09 (+1.81%) Closing price 04:00 PM EasternExtended Trading$5.08 +0.03 (+0.50%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GDRX vs. LYFT, ETSY, AMTM, MARA, WSC, SEZL, LIF, QBTS, FTDR, and STNEShould you be buying GoodRx stock or one of its competitors? The main competitors of GoodRx include Lyft (LYFT), Etsy (ETSY), Amentum (AMTM), Marathon Digital (MARA), WillScot (WSC), Sezzle (SEZL), Life360 (LIF), D-Wave Quantum (QBTS), Frontdoor (FTDR), and StoneCo (STNE). These companies are all part of the "business services" industry. GoodRx vs. Its Competitors Lyft Etsy Amentum Marathon Digital WillScot Sezzle Life360 D-Wave Quantum Frontdoor StoneCo GoodRx (NASDAQ:GDRX) and Lyft (NASDAQ:LYFT) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations. Which has better earnings and valuation, GDRX or LYFT? Lyft has higher revenue and earnings than GoodRx. GoodRx is trading at a lower price-to-earnings ratio than Lyft, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGoodRx$792.32M2.28$16.39M$0.0863.13Lyft$5.79B1.13$22.78M$0.15104.73 Which has more volatility & risk, GDRX or LYFT? GoodRx has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Lyft has a beta of 2.2, indicating that its stock price is 120% more volatile than the S&P 500. Do analysts rate GDRX or LYFT? GoodRx currently has a consensus price target of $6.55, suggesting a potential upside of 29.61%. Lyft has a consensus price target of $16.64, suggesting a potential upside of 5.91%. Given GoodRx's stronger consensus rating and higher probable upside, analysts plainly believe GoodRx is more favorable than Lyft.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GoodRx 0 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.64Lyft 1 Sell rating(s) 25 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.23 Does the media favor GDRX or LYFT? In the previous week, Lyft had 31 more articles in the media than GoodRx. MarketBeat recorded 32 mentions for Lyft and 1 mentions for GoodRx. GoodRx's average media sentiment score of 0.93 beat Lyft's score of 0.31 indicating that GoodRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lyft 6 Very Positive mention(s) 8 Positive mention(s) 10 Neutral mention(s) 6 Negative mention(s) 1 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in GDRX or LYFT? 63.8% of GoodRx shares are held by institutional investors. Comparatively, 83.1% of Lyft shares are held by institutional investors. 4.5% of GoodRx shares are held by insiders. Comparatively, 3.1% of Lyft shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is GDRX or LYFT more profitable? GoodRx has a net margin of 3.57% compared to Lyft's net margin of 0.95%. Lyft's return on equity of 11.28% beat GoodRx's return on equity.Company Net Margins Return on Equity Return on Assets GoodRx3.57% 7.85% 3.91% Lyft 0.95%11.28%1.50% SummaryLyft beats GoodRx on 9 of the 17 factors compared between the two stocks. Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GDRX vs. The Competition Export to ExcelMetricGoodRxMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.77B$7.46B$5.54B$8.87BDividend YieldN/A2.77%5.39%4.10%P/E Ratio63.1328.1026.1719.90Price / Sales2.2832.01414.67113.66Price / Cash15.5921.4136.1356.90Price / Book2.676.628.055.38Net Income$16.39M$230.16M$3.15B$248.50M7 Day Performance2.85%3.57%1.85%2.97%1 Month Performance32.20%5.73%4.81%6.02%1 Year Performance-35.42%33.35%34.86%20.39% GoodRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GDRXGoodRx3.0513 of 5 stars$5.05+1.8%$6.55+29.6%-36.6%$1.77B$792.32M63.13950LYFTLyft3.8798 of 5 stars$14.95+2.9%$16.40+9.7%+15.9%$6.25B$5.96B99.672,934Trending NewsETSYEtsy3.6468 of 5 stars$53.92-4.0%$49.87-7.5%-9.9%$5.62B$2.81B38.512,400Analyst ForecastAMTMAmentum2.2776 of 5 stars$21.94+0.5%$25.22+15.0%N/A$5.34B$8.39B0.0053,000MARAMarathon Digital1.8582 of 5 stars$14.18-1.0%$20.94+47.7%-30.4%$4.99B$656.38M-9.789Options VolumeWSCWillScot4.3476 of 5 stars$26.72+1.9%$40.63+52.0%-23.9%$4.87B$2.40B296.924,500SEZLSezzle2.2463 of 5 stars$144.98-1.4%$96.94-33.1%+1,030.4%$4.83B$271.13M48.98540Analyst ForecastInsider TradeLIFLife3601.5049 of 5 stars$61.78-0.3%$58.67-5.0%+102.9%$4.73B$371.48M686.44600Analyst ForecastInsider TradeQBTSD-Wave Quantum1.5086 of 5 stars$14.92-4.7%$13.57-9.0%+1,275.9%$4.36B$8.83M-24.873Trending NewsAnalyst ForecastGap UpFTDRFrontdoor3.1996 of 5 stars$59.03+0.8%$54.00-8.5%+76.5%$4.34B$1.89B19.102,120Positive NewsSTNEStoneCo3.4663 of 5 stars$14.96+3.0%$15.63+4.4%+37.6%$4.28B$13.27B-19.1816,793 Related Companies and Tools Related Companies Lyft Competitors Etsy Competitors Amentum Competitors Marathon Digital Competitors WillScot Competitors Sezzle Competitors Life360 Competitors D-Wave Quantum Competitors Frontdoor Competitors StoneCo Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GDRX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.